Name | Title | Contact Details |
---|
Unlike traditional approaches that only address symptoms, Cardionomic addresses the conditions root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality. This breakthrough therapy is also expected to increase pharmacological tolerance at discharge, which will reduce costly readmission and extend life. Spun off from Denali Medical II, a New Enterprise Associates (NEA) backed incubator, Cardionomic is funded by NEA, Greatbatch Medical and Cleveland Clinic Foundation.
St. Francis Health Center is a Topeka, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Pioneer Medical Group is a leader in the Hospitalist movement, providing the highest level of Hospital Medicine and Post Transition Care to Florida Hospitals in the West and Central Florida Region.
The Araz Group is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mercola.com is a Hoffman Estates, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.